Dr. Carlos I. Bustamante, MD

Dr. Bustamante practices at Jackson North Medical Center - Nuclear Medicine - HOPD in North Miami Beach, Florida.

Dr. Bustamante's NPI, 1649216953, was assigned on June 22, 2006. Dr. Bustamante graduated from Central University of Venezuela in 1976. Dr. Bustamante holds Florida license ME0059145.

Dr. Bustamante's primary practice is Jackson North Medical Center - Nuclear Medicine - HOPD, at 160 Nw 170th Street, North Miami Beach, FL 33169.

Dr. Bustamante's primary practice is Jackson North Medical Center - Nuclear Medicine - HOPD in North Miami Beach, Florida. Dr. Bustamante is also affiliated with Jackson Memorial Hospital. The medical group on file is InfectionRX. Dmand AI also links Dr. Bustamante to 1 more hospital, 2 group practices and clinics and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Bustamante practices, 5 sites in all. Vendor and product names are available with a free account.

Infectious disease is Dr. Bustamante's primary specialty in the NPI Registry, under taxonomy code 207RI0200X. Dr. Bustamante is board certified in infectious disease by the American Board of Internal Medicine. Dr. Bustamante is licensed in Florida.

Dmand AI lists hiv/aids and joint or bone infection among the conditions Dr. Bustamante treats.

CMS data shows 1,139 Medicare services from Dr. Bustamante across 5 procedure codes in 2024, for 310 Medicare patients. Medicare paid $85,258 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 310 Medicare patients who saw Dr. Bustamante in 2024. The largest group is 75 to 84, with 96 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 61% are also on Medicaid. Their average risk score is 4.86, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Bustamante's median patient age at 64, with 46% women.

In 2024, Dr. Bustamante wrote 587 Medicare Part D claims for 58 patients. 17% of them were for generic drugs. CMS names the drug for 499 of them, across 7 drugs with 11 or more claims each, at $1,655,455 in total drug cost. In 2023, CMS named 444 claims across 5 drugs.

Dr. Bustamante accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Dmand AI links 2 papers to Dr. Bustamante. Dr. Bustamante has published most often in Mycopathologia. Dr. Bustamante's most frequent co-author is Glenn D. Gilmor, MD.

CMS Open Payments shows 469 general payments to Dr. Bustamante from 30 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 43% of the total. Merck Sharp & Dohme Corporation paid the most, $13,139.

Dr. Bustamante graduated from Central University of Venezuela in 1976.

Dr. Bustamante is in network with 16 carriers, including Aetna, Blue Cross Blue Shield of Michigan and United Healthcare. HMO plans come from the most carriers, 9. Check the plan with the practice before a visit.